Official Press Conference Programme

Wednesday, 27 July

10:00 – 11:00 EDT / 16:00 – 17:00 CEST

Format: Virtual

Registration: Register here

OFFICIAL PRESS CONFERENCE

Scientific Highlights

  • (Chair) Sharon Lewin, IAS President-Elect (Australia)
  • Núria Climent, Hospital Clinic-IDIBAPS/ University of Barcelona (Spain)
    Exceptional post-treatment control associated with strong NK and ϒɗ cytotoxic T-cells
  • Jana Dickter, City of Hope (USA)
    The “City of Hope” Patient: Prolonged HIV-1 remission without antiretrovirals (ART) after allogeneic hematopoietic stem cell transplantation (aHCT) of CCR5-Δ32/Δ32 donor cells for acute myelogenous leukemia (AML)
  • Annie Luetkemeyer, Zuckerberg San Francisco General Hospital, UCSF (USA)
    Doxycycline post-exposure prophylaxis for STI prevention among MSM and Transgender Women on HIV PrEP or living with HIV: High efficacy to reduce incident STI’s in a randomized trial
  • Eli Boritz, Vaccine Research Center, NIAID (USA)
    Transcriptional programs of HIV silencing and cell survival in HIV-infected memory CD4 T cells under antiretroviral therapy
  • Madisa Mine, Botswana Ministry of Health and Wellness (Botswana)
    Botswana achieved the Joint United Nations Programme on HIV/AIDS (UNAIDS) 95-95-95 targets: Results from the Fifth Botswana HIV/AIDS Impact Survey (BAIS V), 2021
  • Anchalee Avihingsanon, HIV-NAT, Thai Red Cross AIDS Research Centre (Thailand)
    Week 48 Results of a Phase 3 Randomized Controlled Trial of Bictegravir/Emtricitabine/Tenofovir alafenamide (B/F/TAF) vs Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate (DTG+F/TDF) as Initial Treatment in HIV/HBV-Coinfected Adults (ALLIANCE)

14:30 – 15:30 EDT / 20:30 – 21:30 CEST

Format: In person & virtual

Location: Delta Marriott Hotel, 475 Av. du Président-Kennedy, Montreal, Quebec H3A 1J7, Canada

(Media may join in person or via the Zoom link below)

Launch of “In Danger” UNAIDS 2022 Global AIDS Update

  • Adeeba Kamarulzaman, University of Malaya (Malaysia)
  • Winnie Byanyima, UNAIDS (Switzerland)
  • Anthony Fauci, National Institute of Allergy and Infectious Diseases (NIAID)
  • John Nkengasong, U.S. Global AIDS Coordinator and Special Representative For Health Diplomacy (USA)
  • Andriy Klepikov, Alliance for Public Health (Ukraine)
  • Anita Vandenbeld MP, Parliamentary Secretary to the Minister of International Development (Canada)
  • Keren Dunaway, International Community of Women Living with HIV (Argentina)

Thursday, 28 July

10:00 – 11:00 EDT / 16:00 – 17:00 CEST

Format: Virtual

Registration: Register here

OFFICIAL PRESS CONFERENCE

Long-Acting PrEP for HIV Prevention: New Evidence, New Momentum

  • (Chair) Adeeba Kamarulzaman, IAS President and AIDS 2022 International Co-Chair (Malaysia)
  • Sinead Delany-Moretlwe, University of the Witwatersrand (South Africa)
    Long acting cabotegravir: updated efficacy and safety results from HPTN 084
  • Beatriz Grinsztejn, Evandro Chagas National Institute of Infectious Diseases – Fiocruz (Brazil)
    Transgender Women (TGW) in HPTN 083: An Evaluation of Safety, Efficacy, and Gender Affirming Hormonal Therapy (GAHT) Interactions with Long-acting Cabotegravir (CAB-LA)
  • Meg Doherty, World Health Organization (Switzerland)
    Launch of WHO CAB-LA Guidelines
  • Charles Gore, Medicines Patent Pool (Switzerland)
    Deborah Waterhouse, ViiV Healthcare (USA)
    Update on ViiV Healthcare and Medicine Patent Pool negotiations on CAB-LA for PrEP in Low- and Middle-Income Countries
  • Tenu Avafia, Unitaid (Switzerland)
    New Plans and Partnerships to Speed Equitable Access to Longer-acting HIV Prevention Products

Friday, 29 July

08:00 – 09:00 EDT / 14:00 – 15:00 CEST

Format: In person & virtual

Room: Media Centre press conference room

Registration: Register here

OFFICIAL PRESS CONFERENCE

AIDS 2022 Official Opening Press Conference

  • (Chair) Adeeba Kamarulzaman, IAS President and AIDS 2022 International Co-Chair (Malaysia)
  • Ambassador John N. Nkengasong, U.S. Global AIDS Coordinator and Special Representative for Health Diplomacy (USA)
  • Winnie Byanyima, UNAIDS (Switzerland)
  • Maurine Murenga, Executive Director of Lean on Me Foundation and Coordinator, TB Women Global (Kenya)
    Update on the revolutionary global U=U movement

12:00 EDT / 16:00 CEST

VIRTUAL THIRD PARTY PRESS CONFERENCE

Report launch on interlinkages of climate change with sexual and reproductive health and rights (SRHR) and bodily autonomy in Asia and the Pacific

Organizer: CNS

16:00 EDT / 22:00 CEST

VIRTUAL THIRD PARTY PRESS CONFERENCE

Lessons learned from the COVID-19 pandemic: How can we ensure uninterrupted HIV services during health emergencies?

Organizer: National Coalition of People Living with HIV in India and CNS

17:00 EDT / 23:00 CEST

VIRTUAL THIRD PARTY PRESS CONFERENCE

Organizer: AIDS Society of India

Saturday, 30 July

12:00 EDT / 18:00 CEST

VIRTUAL THIRD PARTY PRESS CONFERENCE

Overview of the host country of the upcoming International Conference on AIDS and STIs in Africa (ICASA 2023)

Organizer: Society for AIDS in Africa

Sunday, 31 July

12:00 EDT / 18:00 CEST

VIRTUAL THIRD PARTY PRESS CONFERENCE

Adolescents living with HIV: Are there gaps in addressing social, economic, and cultural realities?

Organizer: Gujarat AIDS Prevention Unit

Monday, 01 August

01:00 EDT / 07:00 CEST / 13:00 HKT

VIRTUAL THIRD PARTY PRESS CONFERENCE

Unacceptable: People living with HIV but at risk of dying of tuberculosis and noncommunicable diseases

Organizer: Asia Pacific Media Alliance for Health and Development

13:00 EDT / 19:00 CEST

VIRTUAL THIRD PARTY PRESS CONFERENCE

Reshaping Global Public Health and HIV

Organizer: AIDS Healthcare Foundation

16:15 EDT / 22:15 CEST

HYBRID PRESS CONFERENCE

Government of Canada to make an announcement to advance the domestic HIV response

Organizer: The Government of Canada

Find out more here.

14:15 – 15:15 EDT / 20:15 – 21:15 CEST

Format: In person & virtual

Room: 517a/Channel 3

MEDIA SYMPOSIUM

The future of HIV media coverage

  • (Chair) André Picard, The Globe and Mail (Canada)
  • Apoorva Mandavilli, New York Times (USA)
  • Roxanne Khamsi, Nature; The Atlantic; and WIRED (Canada)
  • Sipokazi Fokazi, Sunday Times; and TimesLIVE, (South Africa)
  • Jon Cohen, Science, (USA)
  • Su Lyn Boo, Code Blue, (Malaysia)
  • Sarah Boseley, The Guardian, (UK)